Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma. - Wang WY; Hsu TW; Su YH; Su CM; Wang TH; Chiu CF; Tsai KY; Huang CY; Chen HA; Liao PH (International journal of medical sciences, 2025)